KIMSNSEKrishna Institute of Medical Sciences Limited· Healthcare ServicesHighNeutral
Announced Fri, 7 Nov, 2025 · 15:40 IST

KIMS gets clean auditor review for Q2 and H1 FY26

KIMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.4%Reaction day
₹725.00
prior close
₹725.00
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)-0.0%-3.4% vs market
Hospital peers, median of 20sector-1.1%-2.4% vs sector

On the reaction day the stock moved 3.4 pts less than Nifty Smallcap 250 and 2.4 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.6
10m
-0.9
15m
-1.1
30m
-1.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.4-0.0-3.4-1.1-2.4
Next day
-7.4-0.2-7.2-2.2-5.2
2d
-5.0+0.6-5.6-2.2-2.7
3d
-6.6+0.2-6.8-2.4-4.2
4d
-8.3+0.4-8.6-2.9-5.4
5d
-6.2+1.0-7.3-1.9-4.3
1w
-8.4-0.4-8.0-1.9-6.5
15d
-5.0-1.5-3.6-3.9-1.1
1m
-8.3-5.0-3.3-8.0-0.2
2m
-15.2-5.4-9.8-9.1-6.1
3m
-10.2-3.9-6.2-12.3+2.1
UpDownMarket · Nifty Smallcap 250Sector · Hospital peers, median of 20Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

KIMS filed the limited review reports from auditor S.R. Batliboi and Associates LLP for Q2 FY26 and H1 FY26 ended September 30, 2025. Both standalone and consolidated review reports are unqualified, with no material misstatements or concerns flagged. Review covers the holding company, 13 subsidiaries, and 1 associate.

Likely market impact

Clean review with no qualifications is positive for shareholders. No red flags from the auditor on accounting quality.